Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Turtle Cameron
Relationship:  
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   759,475    

Indirect Shares

  0      
Direct Value   $794,036    

Indirect Value

  $0      
Total Shares   759,475      
Total Value   $794,036      


Bridgebio Pharma, Inc.
 $345,369 Aeglea Biotherapeutics, Inc.
 $448,667 Bridgebio Pharma, Inc.
 $345,369 Aeglea Biotherapeutics, Inc.
 $448,667
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

      
       
     Stock price went down :
      
       
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Eidos Therapeutics, Inc. EIDX Chief Business Officer 2021-01-26 0 2018-11-30 0    Premium*  
            Bridgebio Pharma, Inc. BBIO See Remarks 2020-12-28 12,568 2019-07-01 0    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE 2024-02-15 746,907 0    Premium*  
* Premium Members only  

Records found :    56         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BBIO Bridgebio Pharma, Inc. See Remarks   •       –      –    2020-11-24 4 AS $47.00 $200,137 D/D (4,258) 12,568 0 %
BBIO Bridgebio Pharma, Inc. See Remarks   •       –      –    2020-11-24 4 OE $17.00 $72,386 D/D 4,258 16,826 0 -
BBIO Bridgebio Pharma, Inc. See Remarks   •       –      –    2020-11-25 4 OE $17.00 $12,614 D/D 742 13,310 0 -
BBIO Bridgebio Pharma, Inc. See Remarks   •       –      –    2020-11-25 4 AS $47.23 $35,044 D/D (742) 12,568 0 %
BBIO Bridgebio Pharma, Inc. See Remarks   •       –      –    2020-12-28 4 OE $0.16 $130,500 D/D 19,500 32,068 0 -
BBIO Bridgebio Pharma, Inc. See Remarks   •       –      –    2020-12-28 4 AS $69.34 $1,357,184 D/D (19,500) 12,568 0 %

  56  Records found
  1   2   3     
  Page 3 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed